Acadia Healthcare (NASDAQ:ACHC) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $18.76 and traded as high as $23.40. Acadia Healthcare shares last traded at $22.83, with a volume of 2,551,744 shares trading hands.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ACHC. Royal Bank Of Canada increased their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Barclays upped their target price on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 3rd. Raymond James Financial reiterated an “outperform” rating and set a $25.00 target price on shares of Acadia Healthcare in a report on Thursday, February 26th. Leerink Partners boosted their price target on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a report on Thursday, February 26th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Stock Up 1.2%

The firm’s 50 day moving average is $19.42 and its 200-day moving average is $18.80. The firm has a market cap of $2.18 billion, a PE ratio of -1.94, a P/E/G ratio of 7.90 and a beta of 0.71. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same period in the previous year, the firm posted $0.64 EPS. Acadia Healthcare’s revenue was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Principal Financial Group Inc. grew its holdings in Acadia Healthcare by 112.1% in the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock valued at $10,967,000 after purchasing an additional 234,107 shares during the period. Vanguard Group Inc. raised its stake in Acadia Healthcare by 7.8% during the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares during the period. Invenomic Capital Management LP boosted its holdings in shares of Acadia Healthcare by 41.6% in the 3rd quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock valued at $47,945,000 after purchasing an additional 568,796 shares during the last quarter. First Citizens Bank & Trust Co. grew its stake in shares of Acadia Healthcare by 164.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after buying an additional 36,733 shares during the period. Finally, Public Sector Pension Investment Board acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth $8,919,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.